Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 120 participants.
Also called NCT02056223
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT02056223 -
2013-004955-19
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Suspended
Technical summary
Registry record NCT02056223. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-09 (actual); primary completion 2019-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
- Acronym
- PARIDA
- Condition
- Ductus Arteriosus Patent
- Condition
- Respiratory Distress Syndrome
- Intervention (Drug)
- Intravenous paracetamol
- Intervention (Drug)
- Intravenous ibuprofen
- Lead sponsor
- University of Padova
Record details
- Record id
cardio:ct-nct02056223- Content hash
eb00c19f1b15ceaecf475be190c812bd60d80a95681a42c91a8e2cf0895c661a